Annual D&A
$946.00 K
+$808.00 K+585.51%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual depreciation & amortization is $946.00 thousand, with the most recent change of +$808.00 thousand (+585.51%) on December 1, 2023.
- During the last 3 years, CATX annual D&A has risen by +$797.00 thousand (+534.90%).
- CATX annual D&A is now -26.47% below its all-time high of $1.29 million, reached on June 1, 2009.
Performance
CATX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$669.00 K
+$99.00 K+17.37%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly depreciation & amortization is $669.00 thousand, with the most recent change of +$99.00 thousand (+17.37%) on September 1, 2024.
- Over the past year, CATX quarterly D&A has increased by +$410.00 thousand (+158.30%).
- CATX quarterly D&A is now at all-time high.
Performance
CATX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.85 M
+$410.00 K+28.53%
September 1, 2024
Summary
- As of February 7, 2025, CATX TTM depreciation & amortization is $1.85 million, with the most recent change of +$410.00 thousand (+28.53%) on September 1, 2024.
- Over the past year, CATX TTM D&A has increased by +$1.16 million (+170.03%).
- CATX TTM D&A is now at all-time high.
Performance
CATX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CATX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +585.5% | +158.3% | +170.0% |
| 3 y3 years | +534.9% | +271.7% | +490.1% |
| 5 y5 years | +595.6% | +271.7% | +490.1% |
CATX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +585.5% | at high | +1015.0% | at high | +837.6% |
| 5 y | 5-year | at high | +595.6% | at high | +1867.7% | at high | +1209.9% |
| alltime | all time | -26.5% | >+9999.0% | at high | +4081.3% | at high | +2616.2% |
Perspective Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $669.00 K(+17.4%) | $1.85 M(+28.5%) |
| Jun 2024 | - | $570.00 K(+64.7%) | $1.44 M(+29.2%) |
| Mar 2024 | - | $346.00 K(+32.1%) | $1.11 M(+17.5%) |
| Dec 2023 | $946.00 K(+585.5%) | $262.00 K(+1.2%) | $946.00 K(+38.3%) |
| Sep 2023 | - | $259.00 K(+5.7%) | $684.00 K(+38.7%) |
| Jun 2023 | - | $245.00 K(+36.1%) | $493.00 K(+57.5%) |
| Mar 2023 | - | $180.00 K(+164.7%) | $313.00 K(+21.8%) |
| Dec 2022 | $138.00 K(-44.4%) | - | - |
| Sep 2022 | - | $68.00 K(+4.6%) | $257.00 K(+3.6%) |
| Jun 2022 | - | $65.00 K(+1.6%) | $248.00 K(+10.2%) |
| Jun 2022 | $248.00 K(+66.4%) | - | - |
| Mar 2022 | - | $64.00 K(+6.7%) | $225.00 K(+14.2%) |
| Dec 2021 | - | $60.00 K(+1.7%) | $197.00 K(+13.2%) |
| Sep 2021 | - | $59.00 K(+40.5%) | $174.00 K(+16.8%) |
| Jun 2021 | $149.00 K(+1.4%) | - | - |
| Jun 2021 | - | $42.00 K(+16.7%) | $149.00 K(+5.7%) |
| Mar 2021 | - | $36.00 K(-2.7%) | $141.00 K(0.0%) |
| Dec 2020 | - | $37.00 K(+8.8%) | $141.00 K(-1.4%) |
| Sep 2020 | - | $34.00 K(0.0%) | $143.00 K(-2.7%) |
| Jun 2020 | $147.00 K(+8.1%) | $34.00 K(-5.6%) | $147.00 K(-1.3%) |
| Mar 2020 | - | $36.00 K(-7.7%) | $149.00 K(+0.7%) |
| Dec 2019 | - | $39.00 K(+2.6%) | $148.00 K(+4.2%) |
| Sep 2019 | - | $38.00 K(+5.6%) | $142.00 K(+4.4%) |
| Jun 2019 | $136.00 K(+70.0%) | $36.00 K(+2.9%) | $136.00 K(+9.7%) |
| Mar 2019 | - | $35.00 K(+6.1%) | $124.00 K(+13.8%) |
| Dec 2018 | - | $33.00 K(+3.1%) | $109.00 K(+16.0%) |
| Sep 2018 | - | $32.00 K(+33.3%) | $94.00 K(+17.5%) |
| Jun 2018 | $80.00 K(+17.6%) | $24.00 K(+20.0%) | $80.00 K(+8.1%) |
| Mar 2018 | - | $20.00 K(+11.1%) | $74.00 K(+2.8%) |
| Dec 2017 | - | $18.00 K(0.0%) | $72.00 K(+2.9%) |
| Sep 2017 | - | $18.00 K(0.0%) | $70.00 K(+2.9%) |
| Jun 2017 | $68.00 K(-85.6%) | $18.00 K(0.0%) | $68.00 K(-37.6%) |
| Mar 2017 | - | $18.00 K(+12.5%) | $109.00 K(-52.4%) |
| Dec 2016 | - | $16.00 K(0.0%) | $229.00 K(-34.6%) |
| Sep 2016 | - | $16.00 K(-72.9%) | $350.00 K(-25.7%) |
| Jun 2016 | $471.00 K(-18.2%) | $59.00 K(-57.2%) | $471.00 K(-14.2%) |
| Mar 2016 | - | $138.00 K(+0.7%) | $548.80 K(+0.7%) |
| Dec 2015 | - | $137.00 K(0.0%) | $544.90 K(+0.3%) |
| Sep 2015 | - | $137.00 K(+0.1%) | $543.10 K(-5.7%) |
| Jun 2015 | $576.00 K | $136.80 K(+2.0%) | $576.10 K(-5.1%) |
| Mar 2015 | - | $134.10 K(-0.8%) | $607.10 K(-5.3%) |
| Dec 2014 | - | $135.20 K(-20.5%) | $641.30 K(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $170.00 K(+1.3%) | $679.00 K(-0.9%) |
| Jun 2014 | $685.40 K(-7.3%) | $167.80 K(-0.3%) | $685.30 K(-1.1%) |
| Mar 2014 | - | $168.30 K(-2.7%) | $692.80 K(-1.1%) |
| Dec 2013 | - | $172.90 K(-1.9%) | $700.20 K(-1.3%) |
| Sep 2013 | - | $176.30 K(+0.6%) | $709.10 K(-4.1%) |
| Jun 2013 | $739.10 K(-12.7%) | $175.30 K(-0.2%) | $739.20 K(-3.7%) |
| Mar 2013 | - | $175.70 K(-3.4%) | $767.80 K(-4.0%) |
| Dec 2012 | - | $181.80 K(-11.9%) | $799.90 K(-4.4%) |
| Sep 2012 | - | $206.40 K(+1.2%) | $836.80 K(-1.2%) |
| Jun 2012 | $847.10 K(-4.7%) | $203.90 K(-1.9%) | $847.20 K(-1.9%) |
| Mar 2012 | - | $207.80 K(-5.0%) | $863.70 K(-1.6%) |
| Dec 2011 | - | $218.70 K(+0.9%) | $877.30 K(-0.4%) |
| Sep 2011 | - | $216.80 K(-1.6%) | $880.80 K(-0.9%) |
| Jun 2011 | $888.60 K(-6.8%) | $220.40 K(-0.5%) | $888.50 K(-1.5%) |
| Mar 2011 | - | $221.40 K(-0.4%) | $902.30 K(-1.4%) |
| Dec 2010 | - | $222.20 K(-1.0%) | $915.40 K(-2.1%) |
| Sep 2010 | - | $224.50 K(-4.1%) | $934.90 K(-1.9%) |
| Jun 2010 | $953.20 K(-25.9%) | $234.20 K(-0.1%) | $953.30 K(-13.3%) |
| Mar 2010 | - | $234.50 K(-3.0%) | $1.10 M(-5.7%) |
| Dec 2009 | - | $241.70 K(-0.5%) | $1.17 M(-4.9%) |
| Sep 2009 | - | $242.90 K(-36.2%) | $1.23 M(-4.7%) |
| Jun 2009 | $1.29 M(+21.3%) | $380.80 K(+26.5%) | $1.29 M(+7.2%) |
| Mar 2009 | - | $301.00 K(-0.1%) | $1.20 M(+8.4%) |
| Dec 2008 | - | $301.20 K(-0.8%) | $1.11 M(-4.2%) |
| Sep 2008 | - | $303.50 K(+3.0%) | $1.16 M(+9.0%) |
| Jun 2008 | $1.06 M(+48.3%) | $294.80 K(+41.9%) | $1.06 M(-3.4%) |
| Mar 2008 | - | $207.80 K(-40.7%) | $1.10 M(+7.8%) |
| Dec 2007 | - | $350.20 K(+68.3%) | $1.02 M(+28.4%) |
| Sep 2007 | - | $208.10 K(-37.4%) | $794.10 K(+11.0%) |
| Jun 2007 | $715.20 K(+9.1%) | $332.40 K(+158.3%) | $715.20 K(+5.5%) |
| Mar 2007 | - | $128.70 K(+3.0%) | $677.70 K(-4.6%) |
| Dec 2006 | - | $124.90 K(-3.3%) | $710.40 K(+4.0%) |
| Sep 2006 | - | $129.20 K(-56.2%) | $682.90 K(+4.2%) |
| Jun 2006 | $655.30 K(>+9900.0%) | $294.90 K(+82.7%) | $655.30 K(+81.8%) |
| Mar 2006 | - | $161.40 K(+65.7%) | $360.40 K(+81.1%) |
| Dec 2005 | - | $97.40 K(-4.1%) | $199.00 K(+95.9%) |
| Sep 2005 | - | $101.60 K | $101.60 K |
| Sep 1998 | $900.00(-52.6%) | - | - |
| Sep 1997 | $1900.00(-99.4%) | - | - |
| Sep 1996 | $316.70 K(-22.3%) | - | - |
| Sep 1995 | $407.40 K(+31.9%) | - | - |
| Sep 1994 | $308.80 K | - | - |
FAQ
- What is Perspective Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Perspective Therapeutics?
- What is Perspective Therapeutics annual D&A year-on-year change?
- What is Perspective Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly D&A year-on-year change?
- What is Perspective Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Perspective Therapeutics?
- What is Perspective Therapeutics TTM D&A year-on-year change?
What is Perspective Therapeutics annual depreciation & amortization?
The current annual D&A of CATX is $946.00 K
What is the all time high annual D&A for Perspective Therapeutics?
Perspective Therapeutics all-time high annual depreciation & amortization is $1.29 M
What is Perspective Therapeutics annual D&A year-on-year change?
Over the past year, CATX annual depreciation & amortization has changed by +$808.00 K (+585.51%)
What is Perspective Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CATX is $669.00 K
What is the all time high quarterly D&A for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly depreciation & amortization is $669.00 K
What is Perspective Therapeutics quarterly D&A year-on-year change?
Over the past year, CATX quarterly depreciation & amortization has changed by +$410.00 K (+158.30%)
What is Perspective Therapeutics TTM depreciation & amortization?
The current TTM D&A of CATX is $1.85 M
What is the all time high TTM D&A for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM depreciation & amortization is $1.85 M
What is Perspective Therapeutics TTM D&A year-on-year change?
Over the past year, CATX TTM depreciation & amortization has changed by +$1.16 M (+170.03%)